Last reviewed · How we verify

Standard Duration Combination NRT

University of Wisconsin, Madison · FDA-approved active Small molecule

Standard Duration Combination NRT delivers multiple forms of nicotine replacement therapy simultaneously to reduce withdrawal symptoms and support smoking cessation.

Standard Duration Combination NRT delivers multiple forms of nicotine replacement therapy simultaneously to reduce withdrawal symptoms and support smoking cessation. Used for Smoking cessation in adults with nicotine dependence.

At a glance

Generic nameStandard Duration Combination NRT
SponsorUniversity of Wisconsin, Madison
Drug classNicotine replacement therapy combination
TargetNicotinic acetylcholine receptors
ModalitySmall molecule
Therapeutic areaSmoking Cessation / Addiction Medicine
PhaseFDA-approved

Mechanism of action

This combination approach uses nicotine in different formulations (typically a longer-acting patch combined with shorter-acting oral forms like gum or lozenge) to provide sustained baseline nicotine levels while allowing flexible dosing for breakthrough cravings. The combination addresses both the chronic nicotine dependence and acute withdrawal symptoms more effectively than monotherapy.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results